Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema - Zehetner, C; Kirchmair, R; Huber, S (Br J Ophthalmol, 2013)